Recent Finacing
Recent Raise
Humanetics develops BIO 300, a prophylactic radioprotectant drug intended to prevent acute radiation injury for military, first responders, and civilians.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Humanetics.
